相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mucosal Polyinosinic-Polycytidylic Acid Improves Protection Elicited by Replicating Influenza Vaccines via Enhanced Dendritic Cell Function and T Cell Immunity
Jose V. Perez-Giron et al.
JOURNAL OF IMMUNOLOGY (2014)
Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Avian influenza A H10N8-a virus on the verge?
Adolfo Garcia-Sastre et al.
LANCET (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Molecular Signatures of Hemagglutinin Stem-Directed Heterosubtypic Human Neutralizing Antibodies against Influenza A Viruses
Yuval Avnir et al.
PLOS PATHOGENS (2014)
Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults
Maria Ines Barria et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant
L. Martinez-Gil et al.
JOURNAL OF VIROLOGY (2013)
Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
Hongquan Wan et al.
JOURNAL OF VIROLOGY (2013)
Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine
Steven Rockman et al.
JOURNAL OF VIROLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
Marc Gurwith et al.
LANCET INFECTIOUS DISEASES (2013)
Natural and long-lasting cellular immune responses against influenza in the M2e-immune host
M. Schotsaert et al.
MUCOSAL IMMUNOLOGY (2013)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar et al.
NATURE MEDICINE (2013)
A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
Louis F. Fries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Aluminum Hydroxide Adjuvant Differentially Activates the Three Complement Pathways with Major Involvement of the Alternative Pathway
Esin Guven et al.
PLOS ONE (2013)
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
Maria Vono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
Jiaxi Wu et al.
SCIENCE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics
Philip R. Dormitzer et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mucosal Adjuvants for Influenza Virus-Like Particle Vaccine
Fu-Shi Quan et al.
VIRAL IMMUNOLOGY (2013)
Influenza virus hemagglutinin stalk-based antibodies and vaccines
Florian Krammer et al.
CURRENT OPINION IN VIROLOGY (2013)
Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
Armin Hekele et al.
EMERGING MICROBES & INFECTIONS (2013)
Alum Directly Modulates Murine B Lymphocytes to Produce IgG1 Isotype
Bo-Ra Jin et al.
Immune Network (2013)
Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection
Nicole Schmitz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Influenza vaccines: T-cell responses deserve more attention
Michael Schotsaert et al.
EXPERT REVIEW OF VACCINES (2012)
Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms
K. Kai McKinstry et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution
Kim B. Westgeest et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Type II NKT cells facilitate Alum-sensing and humoral immunity
Hemangi B. Shah et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-Type H5N1 Influenza Challenge and Controls Viral Loads Better than Subunit H5N1 Vaccine by Eliciting High-Affinity Antibodies
Swati Verma et al.
JOURNAL OF VIROLOGY (2012)
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C. Ekiert et al.
NATURE (2012)
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
Tom M. Wilkinson et al.
NATURE MEDICINE (2012)
Intranasal Administration of dsRNA Analog Poly(I:C) Induces Interferon-α Receptor-Dependent Accumulation of Antigen Experienced T Cells in the Airways
Beth McNally et al.
PLOS ONE (2012)
Influenza: Options to Improve Pandemic Preparation
Rino Rappuoli et al.
SCIENCE (2012)
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
Christoph Hatz et al.
VACCINE (2012)
Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection
Fu-Shi Quan et al.
VIROLOGY (2012)
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
Judith D. Easterbrook et al.
VIROLOGY (2012)
Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
Jessica A. Chichester et al.
VIRUSES-BASEL (2012)
Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials
Francois Roman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
Jianhua Sui et al.
CLINICAL INFECTIOUS DISEASES (2011)
Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin
Saleem Basha et al.
HUMAN IMMUNOLOGY (2011)
H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
Philippe Moris et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
Marina Caskey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
Karim El Bakkouri et al.
JOURNAL OF IMMUNOLOGY (2011)
Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus
Mark W. LaMere et al.
JOURNAL OF IMMUNOLOGY (2011)
Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
Daniel F. Hoft et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance
Mark W. LaMere et al.
JOURNAL OF VIROLOGY (2011)
Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children
Rogier Bodewes et al.
JOURNAL OF VIROLOGY (2011)
Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets
R. Bodewes et al.
JOURNAL OF VIROLOGY (2011)
Systems biology of vaccination for seasonal influenza in humans
Helder I. Nakaya et al.
NATURE IMMUNOLOGY (2011)
Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus
Jae-Min Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59
Ali H. Ellebedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus
Yasuko Hatta et al.
VACCINE (2011)
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
Samuele Calabro et al.
VACCINE (2011)
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
Sandra Morel et al.
VACCINE (2011)
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age
R. Baxter et al.
VACCINE (2011)
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
Danuta M. Skowronski et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Cytolytic CD4+ T cells in viral immunity
Damien Z. Soghoian et al.
EXPERT REVIEW OF VACCINES (2010)
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
Davide Corti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model
Joost H. C. M. Kreijtz et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Naturally Occurring Human Monoclonal Antibodies Neutralize both 1918 and 2009 Pandemic Influenza A (H1N1) Viruses
Jens C. Krause et al.
JOURNAL OF VIROLOGY (2010)
Molecular Characterization of In Vivo Adjuvant Activity in Ferrets Vaccinated against Influenza Virus
Yuan Fang et al.
JOURNAL OF VIROLOGY (2010)
Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets
Berend Jan Bosch et al.
JOURNAL OF VIROLOGY (2010)
Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
Nathalie Landry et al.
PLOS ONE (2010)
Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination
Falko Schmeisser et al.
VACCINE (2010)
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
John Steel et al.
MBIO (2010)
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
Guus F. Rimmelzwaan et al.
EXPERT REVIEW OF VACCINES (2009)
Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity
Amy S. McKee et al.
JOURNAL OF IMMUNOLOGY (2009)
Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
Agnieszka Szymczakiewicz-Multanowska et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A Cell Culture (Vero)-Derived H5N1 Whole-Virus Vaccine Induces Cross-Reactive Memory Responses
Hartmut J. Ehrlich et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004-2005 Season to the 2006-2007 Season
Edward A. Belongia et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Yearly influenza vaccinations: a double-edged sword?
Rogier Bodewes et al.
LANCET INFECTIOUS DISEASES (2009)
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec et al.
NATURE IMMUNOLOGY (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
Rogier Bodewes et al.
PLOS ONE (2009)
Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
David J. M. Lewis et al.
PLOS ONE (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift
Scott E. Hensley et al.
SCIENCE (2009)
Receptor-Independent, Direct Membrane Binding Leads to Cell-Surface Lipid Sorting and Syk Kinase Activation in Dendritic Cells
Gilbert Ng et al.
IMMUNITY (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome
Mirjam Kool et al.
JOURNAL OF IMMUNOLOGY (2008)
The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells
Anja Seubert et al.
JOURNAL OF IMMUNOLOGY (2008)
Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production
Hai-Bin Wang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice
Marc-Andre D'Aoust et al.
PLANT BIOTECHNOLOGY JOURNAL (2008)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
Mark Throsby et al.
PLOS ONE (2008)
Molecular and cellular signatures of human vaccine adjuvants
F. Mosca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine
Takeshi Ichinohe et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin
Rick A. Bright et al.
VACCINE (2007)
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada
D. M. Skowronski et al.
VACCINE (2007)
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
Xiao-Song He et al.
JOURNAL OF VIROLOGY (2006)
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
Jiangtao Lin et al.
LANCET (2006)
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults
JJ Treanor et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers
Iain Stephenson et al.
JOURNAL OF VIROLOGY (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Making better influenza virus vaccines?
P Palese
EMERGING INFECTIOUS DISEASES (2006)
Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice
AO Hovden et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Influenza a vaccine based on the extracellular domain of M2: Weak protection mediated via antibody-dependent NK cell activity
A Jegerlehner et al.
JOURNAL OF IMMUNOLOGY (2004)
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
M Mutsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
JA Fan et al.
VACCINE (2004)
Influenza A virus with defective M2 ion channel activity as a live vaccine
T Watanabe et al.
VIROLOGY (2002)
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine
XH Lu et al.
VACCINE (2002)
Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles
T Watanabe et al.
JOURNAL OF VIROLOGY (2002)
A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM™ vaccines and conventional vaccines
GF Rimmelzwaan et al.
VACCINE (2000)
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
J Talon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
